{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:01:15Z","timestamp":1781794875604,"version":"3.54.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,29]]},"DOI":"10.7759\/cureus.81443","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T06:35:46Z","timestamp":1743316546000},"source":"Crossref","is-referenced-by-count":5,"title":["Mental Health Interventions in Refractory Chronic Spontaneous Urticaria: A Call to Expand Treatment Guidelines"],"prefix":"10.7759","author":[{"given":"George N","family":"Konstantinou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrashis","family":"Podder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Konstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA\u00b2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier T","year":"2022","unstructured":"Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al.. The international EAACI\/GA\u00b2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022, 77:734-66. 10.1111\/all.15090","journal-title":"Allergy"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19561","article-title":"The global burden of chronic urticaria for the patient and society","volume":"184","author":"Gon\u00e7alo M","year":"2021","unstructured":"Gon\u00e7alo M, Gimen\u00e9z-Arnau A, Al-Ahmad M, et al.. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021, 184:226-36. 10.1111\/bjd.19561","journal-title":"Br J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/all.13209","article-title":"The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU","volume":"72","author":"Maurer M","year":"2017","unstructured":"Maurer M, Abuzakouk M, B\u00e9rard F, et al.. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy. 2017, 72:2005-16. 10.1111\/all.13209","journal-title":"Allergy"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.03.010","article-title":"Psychological stress and chronic urticaria: a neuro-immuno-cutaneous crosstalk. A systematic review of the existing evidence","volume":"42","author":"Konstantinou GN","year":"2020","unstructured":"Konstantinou GN, Konstantinou GN. Psychological stress and chronic urticaria: a neuro-immuno-cutaneous crosstalk. A systematic review of the existing evidence. Clin Ther. 2020, 42:771-82. 10.1016\/j.clinthera.2020.03.010","journal-title":"Clin Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00389-z","article-title":"Urticaria","volume":"8","author":"Kolkhir P","year":"2022","unstructured":"Kolkhir P, Gim\u00e9nez-Arnau AM, Kulthanan K, Peter J, Metz M, Maurer M. Urticaria. Nat Rev Dis Primers. 2022, 8:61. 10.1038\/s41572-022-00389-z","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-019-0278-3","article-title":"Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis","volume":"9","author":"Konstantinou GN","year":"2019","unstructured":"Konstantinou GN, Konstantinou GN. Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis. Clin Transl Allergy. 2019, 9:42. 10.1186\/s13601-019-0278-3","journal-title":"Clin Transl Allergy"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-022-00641-2","article-title":"Psychiatric comorbidities in children and adolescents with chronic urticaria","volume":"19","author":"Konstantinou GN","year":"2023","unstructured":"Konstantinou GN, Konstantinou GN. Psychiatric comorbidities in children and adolescents with chronic urticaria. World J Pediatr. 2023, 19:315-22. 10.1007\/s12519-022-00641-2","journal-title":"World J Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-72079-6_23","article-title":"Chronic Urticaria Through the Prism of Psycho-Neuro-Immunology: Another \u201cGordian Knot\u201d to Solve","author":"Konstantinou G","year":"2025","unstructured":"Konstantinou G, Konstantinou G. Chronic Urticaria Through the Prism of Psycho-Neuro-Immunology: Another \u201cGordian Knot\u201d to Solve. PsychoNeuroImmunology, Volume 2: Interdisciplinary Approaches to Diseases. Rezaei N, Yazdanpanah N (ed): Springer Nature, Cham, Switzerland; 2025. 655-84. 10.1007\/978-3-031-72079-6_23"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.12.1076","article-title":"Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control","volume":"133","author":"Weller K","year":"2014","unstructured":"Weller K, Groffik A, Church MK, et al.. Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014, 133:1365-72, 1372.e1-6. 10.1016\/j.jaci.2013.12.1076","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2011.09.008","article-title":"Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria","volume":"108","author":"Mathias SD","year":"2012","unstructured":"Mathias SD, Crosby RD, Zazzali JL, Maurer M, Saini SS. Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2012, 108:20-4. 10.1016\/j.anai.2011.09.008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2010.06.011","article-title":"Development of a daily diary for patients with chronic idiopathic urticaria","volume":"105","author":"Mathias SD","year":"2010","unstructured":"Mathias SD, Dreskin SC, Kaplan A, Saini SS, Spector S, Ros\u00e9n KE. Development of a daily diary for patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2010, 105:142-8. 10.1016\/j.anai.2010.06.011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use","volume":"19","author":"Finlay AY","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994, 19:210-6. 10.1111\/j.1365-2230.1994.tb01167.x","journal-title":"Clin Exp Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/all.12313","article-title":"The EAACI\/GA(2) LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update","volume":"69","author":"Zuberbier T","year":"2014","unstructured":"Zuberbier T, Aberer W, Asero R, et al.. The EAACI\/GA(2) LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014, 69:868-87. 10.1111\/all.12313","journal-title":"Allergy"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2023.01.022","article-title":"Omalizumab in chronic spontaneous urticaria (CSU): real-life experience in dose\/interval adjustments and treatment discontinuation","volume":"11","author":"Br\u00e1s R","year":"2023","unstructured":"Br\u00e1s R, Costa C, Lim\u00e3o R, Caldeira LE, Paulino M, Pedro E. Omalizumab in chronic spontaneous urticaria (CSU): real-life experience in dose\/interval adjustments and treatment discontinuation. J Allergy Clin Immunol Pract. 2023, 11:2392-402. 10.1016\/j.jaip.2023.01.022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2021.11.009","article-title":"Assessment of depression, anxiety, and stress in chronic\u00a0urticaria and its correlation with disease severity","volume":"128","author":"Rani S","year":"2022","unstructured":"Rani S, Singh S, Kumar D, Dabas S, Ritu K. Assessment of depression, anxiety, and stress in chronic\u00a0urticaria and its correlation with disease severity. Ann Allergy Asthma Immunol. 2022, 128:330-1. 10.1016\/j.anai.2021.11.009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2022.892673","article-title":"Urticaria in pregnancy and lactation","volume":"3","author":"Kocat\u00fcrk E","year":"2022","unstructured":"Kocat\u00fcrk E, Podder I, Zenclussen AC, Kasperska Zajac A, Elieh-Ali-Komi D, Church MK, Maurer M. Urticaria in pregnancy and lactation. Front Allergy. 2022, 3:892673. 10.3389\/falgy.2022.892673","journal-title":"Front Allergy"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12851","article-title":"Delayed pressure urticaria treated with the selective serotonin reuptake inhibitor escitalopram","volume":"41","author":"Eskeland S","year":"2016","unstructured":"Eskeland S, Tanum L, Halvorsen JA. Delayed pressure urticaria treated with the selective serotonin reuptake inhibitor escitalopram. Clin Exp Dermatol. 2016, 41:526-8. 10.1111\/ced.12851","journal-title":"Clin Exp Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2014.02.030","article-title":"Selective serotonin reuptake inhibitors as a novel class of immunosuppressants","volume":"20","author":"Gobin V","year":"2014","unstructured":"Gobin V, Van Steendam K, Denys D, Deforce D. Selective serotonin reuptake inhibitors as a novel class of immunosuppressants. Int Immunopharmacol. 2014, 20:148-56. 10.1016\/j.intimp.2014.02.030","journal-title":"Int Immunopharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.667978","article-title":"In chronic spontaneous urticaria, comorbid depression linked to higher disease activity, and substance P levels","volume":"12","author":"Memet B","year":"2021","unstructured":"Memet B, Vurgun E, Barlas F, Metz M, Maurer M, Kocat\u00fcrk E. In chronic spontaneous urticaria, comorbid depression linked to higher disease activity, and substance P levels. Front Psychiatry. 2021, 12:667978. 10.3389\/fpsyt.2021.667978","journal-title":"Front Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/345558-mental-health-interventions-in-refractory-chronic-spontaneous-urticaria-a-call-to-expand-treatment-guidelines","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T06:35:48Z","timestamp":1743316548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/345558-mental-health-interventions-in-refractory-chronic-spontaneous-urticaria-a-call-to-expand-treatment-guidelines"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.81443","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,29]]}}}